Roche Launches India’s First Subcutaneous Immunotherapy for Lung Cancer
Roche Pharma India has launched Tecentriq® SC (atezolizumab) in India, marking the country’s first subcutaneous immunotherapy for lung cancer. The […]
SUBCUTANEOUS-IMMUNOTHERAPY
Roche Pharma India has launched Tecentriq® SC (atezolizumab) in India, marking the country’s first subcutaneous immunotherapy for lung cancer. The […]
